The USA ecosystem closed a record US$11.5B in venture capital funding despite a slight shrinkage in deal volume down to 333 deals. This excludes all M&A and IPO deal activities.

We can report that, as at the end of the third quarter of 2020, the United States cumulative funding into digital health ventures has exceeded the same period in 2019 by 75%. This trend is in complete contrast to the other primary regional ecosystems which have witnessed a slow down in funding.

We also focus our analysis on the venture pipeline maturity, category focus, therapeutic priorities and noteworthy deals, exits, partnerships and investors.

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit to learn more about our data or research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit



  • Download the report headlines
  • Access to limited data in HealthTech Alpha


  • Sign up now to download all premium research
  • Access and download all data in HealthTech Alpha
$ 385 /Month
Custom Solution


  • Get full access to unmatched premium research for your organization
  • Additional collaboration features to take your team's research and collaboration to the next level
Let's Talk
Contact Us

© Galen Growth 2024




Total Funding

GGA Score

powered by